RxPrep course book : 2020 Naplex course book

1083 Pages·2020·168.76 MB·English

by  Amy Drew, Karen Shapiro, Angie Veverka, Stephanie D. Garrett, RxPrep (Firm), Chelsea Bombatch

www.rxprep.com
RxPrep
THE REVIEW PROGRAMS TRUSTED
BYTOPSTUDENTS, SCHOOLS AND EMPLOYERS
The RxPrep® Difference
NAPLEX,® MPJE® & CPJE Reviews
Not surehowtolearnitall?The RxPrepVideosandtheTest Bank Assessmentsmatch toeachchapterinthisCourse
Book.The questions intheTest Banks cover the must-know basic competencydruginformation.Find out what you
know and what you need to know before you take the exam.Watchvideos and take assessments on your phone or
.
tablet;downloadtheRxPrepapptoaccessonthego
READ: Includes the simplest and most complete
CD calculationsandbiostatisticsreviews.It'sallhere,ineasy ATTEND:Liveorstreamingvideoreviewsessions.
:Q=iJ steps,forcompleteexamknow-how.
The RxPrep Course Book is the student-preferred
resource for NAPLEX. Includes all topics tested with PRACTICE:Noneedtoguess-exam-styletestsletyou
must-knowkeydrugsandstudytips. knowwhenyouarereadytotest-anddowell.
The RxPrepTest Banks contain case-rich,exam-style
WATCH:Pair theCourseBook withvideolecturesthat questionsthatcoveralltherequiredmaterial.Includes
0' •M emphasizetherequireddruginformation. cumulativepracticeexam.
Focusontopicsthatneedafreshreview,oruseavideo
tobringupatopicscore. UPDATED:Annually.Current,completeandreadyfor
exampreparation.
ORDERTHEVIDEOANDTESTBANKSONLINEATWWW.RXPREP.COM
CONTACTRXPREPFORLIVEREVIEWSANDGROUPRATES
[email protected]
l
...
J«U.*
< MvPashboafd
II r Prep
i
WelcomeloRxPrep . 3 :
CPJEReviews /jg i ) 3
RxPrep’s
Ml 9 S
MPJEAND
3 • &
CPJEREVIEWS
AtiootUa
CogOut CourseManual,
PracticeTests,Videos
andLivereview
DownloadtheRxPrepapptostudyonthego
^G011oIoIOgKlePlay
©2019 ©2020RXPREP,Inc.
Allrightsreserved.Materialcontainedinthisbookcannotbedistributedorreproducedwithoutpermission.
Theauthorsingoodfaithhavemadeeveryattempttoensurethattheinformationincludedinthisbookisaccurateandupto
date.However,thecontentisintendedforinstructionalpurposesonly,thereforetheauthorsmakenoguarantees,offerno
warrantiesorrepresentations,noracceptanyliabilitieswithrespecttotheaccuracyofthecontentcontainedwithin.
TheRxPrepTestBankassessmentsandVideoLecturesforNAPLEX,andtheMPJEandCPJElawreviewcoursescanbefound
ontheRxPrepwebsiteatwww.rxprep.com.Clickon"Store.”
2020 NAPLEX
COURSE BOOK
®
Study Guide for the NAPLEX and Clinical Content
for the CPJE for those testing in 2020
,
KAREN SHAPIRO PHARMD BCPS
/
AWV CHELSEA BOMBATCH PHARMD BCPS
/ /
AMY DREW PHARMD BCPS
^VNA
/ /
.
MM STEPHANIE D GARRETT PHARMD BCPS
/ /
ANGIE VEVERKA PHARMD BCPS
/ /
2020Contributors
CAITUNDAVIS REZATAHERI
PHARMD BCPS PHARMD,MBA
/
.
KARENGOUD MICHAELJ FREUDIGER
PHARMD BCPS PHARMD APH,BCPS,
/ BCGP / IMP/to
MINDYHOLCOMBE
PHARMD BCPS,BCPPS D.RAYMONDWEBER
/
PHARMD BSPHARM, o
/
DACYLIM BCOP,BCPS,RPH CO o
EDITORIALASSISTANT LU c
AND ;o
TESSAOVERMAN MS.SHANNONZINDA CO
PHARMD,BCPS *7
BOOKDES/GNAND
PRODUCTION
°
?0z
CHAPTERTABLEOFCONTENTS
INCIUCMNGREQUIREDFORMULAS
3 GramsofNitrogenFromGramsofProtein 152
PREPARINGFOR NAPLEX 1 IMMUNIZATIONS
ti CorrectedCalciumforAlbumin<3.5 159
^7 12.CalculationsIV:Clinical. 166 &TRAVELERS 314
I
U BodyMassIndex(BMI) 166
IdealBodyWeight(IBW) 167
AdjustedBodyWeight(AdjBW.-J 167
SelectingandCalculatingPatientWeights 168
1.PreparingforNAPLEXwiththe RowRates.... - 169
RxPrepCourse 3 DropFactor. - 172 20.Immunizations 316
QuickGuides 13 Dehydration 174 21. Travelers. 333
HowtoUsetheRxPrepCourseBook...„.14 Cockcrott-GaultEquation.. 175
TopOutpatientDrugs .15 ArterialBloodGases(ABG) 177 INFECTIOUSDISEASES 340
TopInpatientDrugs.... 19 AnionGap 178
TopOTCDrugs 23 pHCalculations 179
RequiredFormulas. 25 PercentIonization. .182
!»•••«•«»* ...
DiagnosticTests 27 DrugConversions. .183
MedicalTerms...M*»M***4**»«*»*«»»M«*M**M«»M*lt(M430 AbsoluteNeutrophilCount(ANC) 184
nm«fM
CommonMedicalAbbreviations 39 13.CalculationsV:Exam-Style 22.IDI:Background&Antibacterials
MathPractice 185
byDrugClass 342
PHARMACYFOUNDATIONS
23.IDII:BacterialInfections 375
PART1 44 BIOSTATISTICS 198
M T 24.IDIII:Antifungals&Antivirals 398
25.IDIV:OpportunisticInfections 412
26.HumanImmunodeficiencyVirus 415
••••••••<
L
<
4 ^ CARDIOVASCULAR
2.LearningBasicScienceConcepts 46 14.Biostatistics 200 CONDITIONS 440
3.LearningDrugInteractions 55 3 Mean,MediumandMode 202
.
4.LearningLabValues&DrugMonitoring 71 Risk RelativeRisk(RR). ....207
..
5.LearningDrugReferences.... 81 RelativeRiskReduction(RRR) ..208
AbsoluteRiskReduction(ARR)., 208
6.LearningDrugFormulations 91 .
NumberNeededtoTreat(NNT) 209
7.LearningIVMedications 99 NumberNeededtoHarm(NNH) 210 27.Dyslipidemia... 442
8.AnsweringCase-BasedExamQuestion 106 OddsRatio(OR) .210 SS FriedewaldEquation 443
SS TemperatureConversion—s HazardRatio(HR) 211 28.Hypertension 458
(Fahrenheit Celsius) 108 SensitivityandSpecificity .214
29.IschemicHeartDisease 474
.. »••••••••
CALCULATIONS 114 COMPOUNDING& 30.AcuteCoronarySyndromes. ..481
HAZARDOUSDRUGS 223 31.ChronicHeartFailure 489
•••••••••••a
32.Arrhythmias 505
33.Stroke 517
ANTICOAGULATION&
9.CalculationsI:MathBasics... 116 BLOODDISORDERS 524
•••••••••••••a
SS Liquid(Volume)Conversions.... .117 15.CompoundingI:Basics ••••••••••••••••••••••••••225
Solid(Weight)Conversions 117 16.CompoundingII:Equipment,
HeightConversions 117 Stability&Excipients 249
10.CalculationsII:Compounding 128 8 MmWeighableQty(MWQ) 252
•••••••••••••••••••••
SS PercentageStrength 128 17.CompoundingIII:Documentation
RatioStrength 132 &Preparation.. 267 34.Anticoagulation.... 526
PartsPerMillion(PPM) 134 35.Anemia 542
SpecificGravity(SG). 155 RENAL&LIVER DISEASE 288 ,
36.SickleCellDisease 550
Dilution&Concentration(ChangingStrength
orVolume) — 136
•44444444444444444*444444 EYES,EARS,NOSE& SKIN
Alligation 137
CONDITIONS 554
Osmolarity 139 Mi m
Isotonicity(EValue) I42
MolesandMillimoles 144
Milliequivalents.. . 146 18.RenalDisease 290
U»UUMtitUu*U>
KCISolution(Oral)toTablets- — see#61 19.Hepatitis&LiverDisease 302
11. CalculationsIII:Parenteraland
SS EnteralNutrition 148 37.AllergicRhinitis,Cough&Cold .556
DeterminingFluidNeeds 149 38.CommonConditionsoftheEyesandEars.566
TotalEnergyExpenditure 150 39.CommonSkinConditions. 573
ParenteralNutrition ..151
EnteralNutrition.••4444•44•44444««4444444(44*44«44»#4444»4444*>*4«>»4«4«««»*4»«4444444 151 8 TimetoBurn(TTB)4«444444•••44«•»4444••»•44 587
CHAPTERTABLEOFCONTENTS
INCLUDINGREQUIREDFORMULAS
PULMONARYCONDITIONS& PAIN/RELATED GASTROINTESTINAL
TOBACCOCESSATION 590 CONDITIONS CONDITIONS 954
40.PulmonaryArterialHypertension .592 58.Pain 796 72.GastroesophagealRefluxDisease
41. Asthma 599 59.Migraine 818 &PepticUlcerDisease 956
42.ChronicObstructivePulmonaryDisease...617 60.Gout 825 73.Constipation&Diarrhea 966
43.TobaccoCessation 629 74.InflammatoryBowelDisease 975
ONCOLOGY 831 75.MotionSickness 983
ENDOCRINECONDITIONS..634
PHARMACYFOUNDATIONS
PART2 986
61.Oncologyl:Overview&SideEffect
44.Diabetes 636 Management 832
62.OncologyII:CommonCancerTypes
t% InsulinConversions: beginsat656
InitiatingBasal-BolusInsulininTypeIDiabetes &Treatment 851 76.MedicationSafety&QualityImprovement...988
Insulin-to-CarbohydrateRatio: •2 BSACalculations,usingMosteller 861 77. DrugAllergies&Adverse
Ruleof500forRapid-ActingInsulin DrugReactions.... 1000
Insulin-to-CarbohydrateRatio: PSYCHIATRICCONDITIONS..878 78.Pharmacokinetics 1009
Ruleof450forRegularInsulin
CorrectionFactor:1,800Rulefor 21 Bioavailability(F) 1011
Rapid-ActingInsulin VolumeofDistribution(Vd) 1012
CorrectionFactor:1,500RuleforRegularInsulin Clearance i......ir.•» • 1013
CorrectionDose 3 EliminationRateConstant(Ke) 1016
45.ThyroidDisorders 664 PredictingDrugConcentrations 1016
••••444«4«4*4»»**444*4«••••••••••• 63.Depression 880 Half-Life(Tl/2) . 1017
46.SystemicSteroids& u*Uuutuuu«uu»uuu>iiuuiiiuii
64.Schizophrenia/Psychosis 892 LoadingDose(LD) 1019
AutoimmuneConditions 671 ...
65.BipolarDisorder _ 901 79.Pharmacogenomics 1020
MALE& FEMALEHEALTH....692 66.AttentionDeficitHyperactivityDisorder 80.DietarySupplements,Natural&
(ADHD) 905 ComplementaryMedicine 1024
67. AnxietyDisorders 913 81. EmergencyPreparedness,Toxicology
&Antidotes 1033
68.SleepDisorders:Insomnia,RestlessLegs
Syndrome(RLS)&Narcolepsy 918
PATIENTCASES 1041
47. Contraception&Infertility 694 NEUROLOGICCONDITIONS.924
48.DrugUseinPregnancy&Lactation 707
•••••••44444
49.Osteoporosis,Menopause&
TestosteroneUse 713
50.SexualDysfunction 729
82.Cases,Exam-StylePractice ,.1042
51. BenignProstaticHyperplasia(BPH) .734 ..
69.ParkinsonDisease 926
52.OveractiveBladder 740 70.Alzheimer’sDisease 932 INDEX. ...1050
SPECIALPOPULATIONS 746 71. Seizures/Epilepsy .937
22 PhenytoinCorrectionforAlbumin<3,5 946
ByClassification+DrugName 1050
53.Acute&CriticalCareMedicine 748
••••»441
54.PediatricConditions 763
55.CysticFibrosis 773
56.Transplant 779
57. WeightLoss 789
CONTENT LEGEND
(jjf)=RequiredFormula
KEYDRUGGUY ANDSTUDYTIPGALTABLEOFCONTENTS
PHARMACYFOUNDATIONS RENAL& LIVER DISEASE 288 CARDIOVASCULAR
PART1 44 CONDITIONS 440
18.RenalDisease 290
2. LearningBasicScienceConcepts 46 SelectDrugsthatCauseKjdneyDisease 292 27.Dyslipidemia 442
. ReceptorPharmacology .49 : CrGvs.GFR—, .292 SelectDrugsCondrtionsthatCanRaiseLDL
3.. LPheaarmrnaicnogdyDn_raumgicIsn:PtehararmcaticoonsD..ynamics .5555 . SACelCecInthDirbuitgosrsthaantdRAeRquBisrefoirADlobsuemoinruTriIan..te—rvalmCK—D.229943 . aDnedtetormrTinriignlgycSetraidtiensTreatme.ntIntensity „ „_443
/ SelectDrugsthatareContraindicatedinCKD 294 BasedonPatientRisk 445
RanisdkOwpitihoiCdosncurrentUseofBenzodiazepines 56 SelectDrugsthatRaisePotassiumLevels 298 . StatinEquivalentDoses 446
:. CPCYhYaPPrIImnndhauicbocitekoirnrssetics:Pharmaco Kinetics — —655097 1.:9.HCStoeemppspaafotnirtsTiosrne&aotfiLnHgievSpeearvtieDtirseisVHeiyraupsseeerksalemia -323090293 2i.8.HDMeaytneparemgriintneginnMgsyAaiodlgdnia-OsnTreatmentBasedonPatientRisk>..4.44544886
.
4. LearningLabValues&DrugMonitoring 71 .. DAAMechanismsandRegimens 303 BloodPressureMonitoring 460
—
TherapeuticDrugLevels -80 Interferons 307 DrugsthatCanIncreaseBloodPressure 460
5. LearningDrugReferences.... > 81 . LabTestsforLiverDisease „ — -309 . HypertensionGuidelineRecommendations 461
i “Color"DrugReferences„ .89 SelectDrugswithBoxedWarningforLiverDamage 310 KeyIVHypertensionMedications.—. .472
6. LearningDrugFormulations 91 29.IschemicHeartDisease 474
7i. PLaetachrnFrineqguIeVncMy.e....d.ications— 9997 I&MTMRUANVEIZLAETRISONS 314 3.0.TArceautmteeCntoArpopnroaarcyhfSorySntdabrloemIscehsemicHeartDisease 448715
DrugswithLeaching'Adsorption/AbsorptionIssues 20.Immunizations 316 j DrugTreatmentofACS 482
withPVCContainers 101 . VaccineTiming&Spacing 319 DrugsforSecondaryPreventionAfterACS .... 488
^-* CCDProooommNtemmocttooRFnnreoDDfrmrriguuLeggirssgahwwtetiiDtthhuDFriiinlltuegerAnRdtemSqouinliurisetitmoranetinRotensquirements 111100004331 * IIPnnnvfleuauelimdnzCoacooVncatrccaacilninVdeaicTcaciptiinso.en.Isntdo—icVaaticocnins.ati.on.. 332205 3.1.CSSieghlnerscotanDnirdcugSHsyemthaparttotCmFasausoilefuSoreyrsWtoolircsHeneaHretaFratiFluareilure 448499901
SequenceandIntervals .. 328
8. AnsweringCase-BasedExamQuestion 106 21.Travelers 333 TreatmentofChronicSystolicHeartFailure. 492
. SelectDrugsandConditionsthatAlterVitalSigns 109 . 32.Arrhythmias 505
. IdentifyingMedicationTherapyProblems no DrugsforTravelers'Diarrhea .335 TheHeart'sNaturalPacemakerandArrhythmias 505
TravelVaccines 336
SelectDrugsthatCanIncreaseorProlong
CALCULATIONS 114 theQTInterval— — .... ... 508
INFECTIOUSDISEASES•••••••••340 . ClassifyingDrugswithVaughanWilliams 508
9. CalculationsI:MathBasics 116 22.IDI:Background&Antibacterials ; AfibRatevs.RhythmControl 509
.. CommonConversions 117 byDrugClass 342 33.Stroke 517
*..* HRDSoareuttwitgointCRogoeURnlapovteuiPornrsndoisopohnoinsprtst—ihoensExam „, ..111122115587 ... CKKeeoyymFFmeeaaottnuurrReeesssooisfftPCaeennptiPhcaialltliohnsospgoerninss ... 333455602 A. NSigTnsIaCndOSyAmpGtomUsoLfSAtroTkeION& 518
1s0.FRCoealaloldcwyuttlohaeStiRuobunmlessitIoYI:foCMuraoAtmhn.spwoeur?nding 111222877 ...* KKAeemyyinFFoeegaattlyuucrreeosssioodffeCQs:auGrinboaooplodennNeeesmwss,BadNews.. 333555835 3B4L.AOntiOcoDaguDlaItSioOn RDERS 525246
— — . KeyFeaturesofMacrolides 359 x AnticoagulantsareforBloodClots 526
.> DCiosmsomcioantioIVnFPlauritdicsle-svs.V„alence 114269 . KKeeyyFFeeaattuurreessooffSTeutlrfaamcyectlhinoexsazole/T-nmethopnm „336601 .* CCoonavgeurlasitoionnbCeatwsceaedneAnticoagulants 553227
11. CalculationsIII:Parenteraland KeyFeaturesofNitrofurantoin —368 : WarfannTabletColors — 535
. EnteralNutrition 148 . DrugsofChoice/ActiveDrugsforSpecificPathogens.....369 35.Anemia .542
CalonesProvidedfromMacronutrients .151 NoRenalDoseAdjustmentRequired —370 . AssessingandTreatingIronDeficiencyAnemia- 544
12.CalculationsIV:Clinical 166
. 23.IDII:BacterialInfections 375 SelectDrugsthatCanCauseHemolyticAnemia 549
HeightinInches. 168 . TimingofPerioperativeAntibiotics 377 36.SickleCellDisease 550
. FinalVolumeofCompoundedIVSolutions 171 . AOMTreatmentinKids:WhentoConsiderObservation...379 KeyVaccinesinSickleCellDisease 551
InterpretingABGs 177 CAPPatientAssessment(StepwiseApproach) 382
13.CalculationsV:Exam-Style . RIPETherapyforTB 386
MathPractice 185 CdifpaleGuidelineRecommendations 394 EYES,EARS,NOSE& SKIN
CONDITIONS 554
MathisReadyforNAPLEXWhen .197 : SymptomsofCommonSTls 395
. Gonorrhea&Chlamydia:TheyOftenGoTogether—....396 37.AllergicRhinitis,Cough&Cold .556
BIOSTATISTICS 198 . PenicillinPregnancyPuzzler 396
DiphenhydramineInPharmacy;It'sEverywhere 559
14.Biostatistics 200 2.4.ILDymIIeI:DAisenatsifeuonrgRainlgsw&orAm?ntivirals.. 339987 .. PCeoduigahtnacnCdoCuoghldaCnodmCbooldPTroredautcmtse:nWt•hCaat'suitnioanNNaemedee?d....556645
; ICnetenrtprarelTtienngdCeonncfyidCeanlcceulIanttieonrvsals 220052 . KeyIssueswithAzoleAntifungals .400 38.CommonConditionsoftheEyesandEars...566
. RoundingRulesforNNTandNNH 210 25.IDIV:OpportunisticInfections 412 DrugsthatCanIncreaseIQP — 567
26.HumanImmunodeficiencyVirus ...415 . GlaucomaTreatmentGoal:DecreaseIOP. .567
COMPOUNDING& . INSTI-BasedRegimen(INSTl*2NRTIs) 4I8 ^ CChoamnmgeosnoDrrDuagmsaKgneo—wn—toC.auseVision 571
HAZARDOUSDRUGS 223 ^ SingleTabletRegimens 419
39.CommonSkinConditions 573
1.5.CompoundingI:Basics ....225 ti KKeeyyFFeeaattuurreessooffNNNRRTITsIs 442203 . AcneTreatmentSummary 574
Pharmacopeias .226 —
HazardousDrugsontheNIOSHList.... .228 .s PKIeaynFdeaPtKurBeosoosftePrisDrugInteractions „442295
ISOAirQualityinthePEC 233
KeyFeaturesofINSTIs 430
16.CompoundingII:Equipment, Administration(Food)Requirements— „.434
Stability&Excipients 249 . ARTAdverseEffectsbyClassandAgent.... 435
: TheHLBNumber 257 DispenseinOriginalContainer••UIUU* 436
17CompoundingIII:Documentation
&Preparation 267
. ReducingParticleSize&CakeBaking 271
.
Suppositones 277
DeterminingtheBUDForCSPs .284
KEYDRUGGUYANDSTUDYTIPGALTABLEOFCONTENTS
68.SleepDisorders:Insomnia,RestlessLegs
PULMONARY CONDITIONS& SPECIALPOPULATIONS 746
Syndrome(RLS)&Narcolepsy 918
TOBACCO CESSATION 590
53.Acute&CriticalCareMedicine 748 ^ SelectDrugsThatCanWorsenInsomnia. 919
.
40.PulmonaryArterialHypertension 592 .. DopamineDosing .•••••••••*•••••••titinnrna753 EzTipforExcellentZzzzzz(Sleep) •>••»•••.«.*i•• 919
^41.SAelsecthtDmruagsthatCanCausePulmonaryFibrosis. 559998 : TGwenoeCraolmPrminocnipCleasufsoersTorfeIaCtiUngInSfehcotcikons 7.75565 NEUROLOGICCONDITIONS.924
. Spirometry;TestsLungFunction . TreatingADHF„ liuUlul .756 69.ParkinsonDisease 926
(HowWelltheLungsWork) 600 54.PediatricConditions 763 . DopamineBlockingDrugsthatCanWorsenPD 926
; MDIsandDPIs. .607 . AvoidinPediatrics..— .770 . ParkinsonDisease:TheCause,Symptomsand
. WithaSpacerMoreDrugGetsIntoTheLungs 611 55.CysticFibrosis 773 PnmaryDrugTreatment 927
42.ChronicObstructivePulmonaryDisease...617 . InhaledMedicationsforCF. .„..774 70.Alzheimer’sDisease .. 932
COPDvsAsthma. 618 CommonIssueswithPancreaticEnzymeProducts 776 ^ KeyDrugsthatCanWorsenDementia- -,- 933
^
43.TobaccoCessation 629 56.Transplant 779 71.Seizures/Epilepsy 937
TreatmentConsiderationsforTobaccoCessation 631 . TransplantDrugs:What'sUsed.When .785 DrugsthatCanLowertheSeizureThreshold 938
. NicotinePatchAdministration. 632 Vaccine-PreventableIllnessinTransplantRecipients 786 DiastatAcudialDispensing. 939
i HowtoChewNicotineGum.... 632 57. WeightLoss 789 :. AEDCousins 940
ENDOCRINECONDITIONS..634 SSeelleeccttDDrruuggsv-CCoonnddiittiioonnsstthhaattCCaannCCaauusseeWWeeiigghhttGLoasins.......779900 . LTaakmeicYtoaulrSVtaitratemrKinistso:CnoAlEoDrssH!tMeUlpIMStUa4»feUt4y«t.t.U<UIUMUUil„„ 994401
Phenytoin/FosphenytoinAdministration 946
. PrescriptionWeightLossDrugs.AvoidorUseCaution 791 .
44.Diabetes 636 AdjustingPhenytoinDoses 949
. DiagnosticCnteria 638 AEDsHaveaLotofDrugInteractions 949
PAIN/RELATEDCONDITIONS »
ComplicationsofDiabetes 639 AEDsareCNSDepressants., 949
AdultTreatmentGoals(ADA)..... 641 58.Pain 796
' DrugsthatCanRaiseBloodGlucose... 641 . AcetaminophenOverdose — 798 GASTROINTESTINAL
. TreatmentAlgonthm. ^ 642 NSAJDsandtheDuctusArteriosus. _799 CONDITIONS•••••••••••••••••a....954
\.. IICnnositnuiaclitneinnCgtroBanatvesedarlIs-nBiosonuluslisn—IPnrsou_dl—iuncts- „. ..666555667 . OOOpppiiioooiiiddd-BAInolldexuregcdyeW.d—aCronninsgtispation 888000882 72.GUlacsetrroDeisseoapsheagealRefluxDisease&Pep.t.ic.956
. KeyDrugsthatCanWorsenGERDSymptoms 957
.:" HMSFaeyuclpelttecoidrtrgosDlsytroeucegCPmseotninhcssaCi(dtNreCisoraeNWnseLTheoredewnlaeeStmrIenBelcelnlocutotdindegGdD)lurucogsTereatment—666665669021 5.9.MCOOoppigmiioormiiaddoiIOnnnvdeMeu.r.icdg.e.orad*sieRneMesTapnnigraaggteoerrmsyeDnetpression(OIRD)Risks 881881118911 7.3.HKCe2oyRnDAsrautngipdsaPwPtiiItohFnoDrem&curDelaaitsaioerndrshAteboasKonrpotwio.n.. 999665609
4:5.SST/eShlxeycortfoDHirduypgDostiahsnyodrroCdidoeinsrmdsitionsthatcan 666645 60.TGnoptuantFormulations _ 828251 ^. DSWerhuleigccshtDtOhraTuCtgastroethRCaeotcCnosamtnipmCaeatiunnsdgefoDriaCrorhnesat.ipation—,—„.„.999676727
; CLeavuostehHyryopxointheyTraobidleistmColors — _666675 GDrouugtsTtrheaattImncernetaBsaesUicnsc.Acid. .882267 74.IMnafilnatemnamncaetoofrRyeBmoiswsieonl:DCiosmeapasreis.onof 975
.
S/SxofHyperthyroidism— 668 CommonCDandUCTreatments 977
. S/SxofThyroidStorm 669 ONCOLOGY 831 75.MotionSickness 983
46.SystemicSteroids& 61.OncologyI:Overview&SideEffect . Scopolamine(TransdermScop)Patch 985
AutoimmuneConditions _ 671 Management .832
: Steroids:LeastPotenttoMostPotent.— — .673 . DosingConsiderationsforSelectHighlyToxicDrugs 835 PHARMACYFOUNDATIONS
^
: ImmunosuppressionfromSteroids 674 ChemoManandMajorToxicitiesof PART2 986
-: TSErereyleathctietnDmgraAutgcousstuTeshIna(DftlaCimlai)nmCaatuiosnewDirtuhgS-ItnedrouicdesdLupus 668724 CHCoyhdmermamotioothnne.CrTahopeRymeAoddtuhjuceenracTptoivyxeDicMrituyeg_dsications.. „..888335788 7.6.MSeeledcticNaattiioonnaSlPaafteietynt&SaQfeutyaGliotyalIsmprovement....998980
. Drug-InducedRaynaud's 686 . Irinotecan(l-Run-To-The-Can) . 846 i DoNotUseAbbreviations 991
62.OncologyII:CommonCancerTypes 77.DrugAllergies&Adverse
MALE& FEMALEHEALTH....692 &Treatment 851 DrugReactions... 1000
*
. ToReduceDoxorubicinCardiotoxicity 864 IntoleranceorAllergy7 1003
47.Contraception&Infertility — 694 HintsforUnderstandingMonodonalAntibodies 872 DrugsMostCommonlyAssociatedw/Photosensitivity...1004
SelectContraceptiveTypes 699 s DrugsCommonlyAssociatedw/TTP 1004
Severe&RareAdverseEffectsofEstrogen 700 PSYCHIATRICCONDITIONS..878 DrugsCommonlyAssociatedw/SevereSkinReactions...1005
ItnofTenrgtilgiteyrDOruvugslaAtioctnL..ik.•e•••E•44n4*|d4o44g»#4e4nousHormones ..706 63.Depression 880 .. EApPineenpichilnlinneAAlleurtgoy-,InojreNctootr?AUdulm• in«i4s4*t4r4•a»•t•i•o••n•444««••••••• 11000067
48.DrugUseinPregnancy&Lactation 707 . SelectDrugsthatCauseorWorsenDepression4*4444»4444««444881 78.Pharmacokinetics.... .1009
Teratogens:DangerinPregnancy 709 DepressionDiagnosis 881 . DrugAbsorption .1010
49.Osteoporosis,Menopause& AntidepressantsSelectAdverseEffects 885 . DoseAdjustmentsforMichaelisMentenKinetics ...1015
; TSDeiealesgcnttooFssaitscetoorforOsnasetnedUoCpsooernod_s_iitsionswithOsteoporosisRisk„.777111344 6..4.MSSeAclehOciIztninohgpibthhiteroerBsne-isaKt/AePenpstidyTechphermoessSsisaenptarated. .888988287 7.9.DSPeohleeascrtamDPraousgcistoivwgeeiothnrPoNhmeagriamctisvaecoTgeesntRomeqicuiIrmepAlicctaiotino?n..s 1.01100222033
:. CaDnarudlcgPiuSrmeuvmaenmndtaioVrnyitfaomrOinsDteopor*osisTreatm—ent ..771156 PPMsiecykdciinhcgoatttiihcoenSsBy/emllsliptctAiotnmDtrispusgyscthhoatticCanCause —889953 80.CDoiemtapryleSmuepnptlaermyeMnetds,icNinaetural& 1024
. HormoneTherapy:HealthRisksandAppropnateUse„„722 65.BipolarDisorder 901 . DifferencesBetweenDietarySupplementsandDrugs..1025
50.SexualDysfunction 729 Lithium-NotEasytoInitiate.. 904 81.EmergencyPreparedness,Toxicology
DrugsthatCanCauseErectile/SexualDysfunction 730 66.AttentionDeficitHyperactivityDisorder &Antidotes 1033
. PDE-5InhibitorDosingGuide 731 (ADHD) 905 CommonSymptomaticTreatment 1035
51.BenignProstaticHyperplasia(BPH) ...734 . Patient-FriendlyFormulationsforStimulants 906 N-AcetylcysteineTreatment —1036
4444444 InitialManagementofSuspectedOpioidOverdose 1036
s DrugsthatCanWorsenBPH 734 67 AnxietyDisorders 913
52.OveractiveBladder 740 ^ SelectDrugsthatCauseAnxiety.—.— 913 CONTENT LEGEND
. AnticholinergicSideEffects.... 742 : SafeUseofBenzodiazepines 916 flU ^»
DecreasingRiskofDryMouth .742 ( )=StudyTipGal =KeyDrugGuy

PREPARING FOR NAPLEX
m
i j f
CONTENTS
CHAPTER 1
PREPARING FOR NAPLEX WITH THE RxPREP COURSE | 3
QUICK GUIDES 113
HOW TO USE THE RxPREP COURSE BOOK | 14
TOP OUTPATIENT DRUGS | 15
TOP INPATIENT DRUGS | 19
TOP OTC DRUGS | 23
REQUIRED FORMULAS | 25
DIAGNOSTIC TESTS I 27
MEDICAL TERMS | 30
COMMON MEDICAL ABBREVIATIONS | 39